Trial Profile

Phase 3 study of SNG001

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 26 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Interferon beta-1a (Primary)
Indications Chronic obstructive pulmonary disease; COVID 2019 infections
Focus Registrational; Therapeutic Use

Most Recent Events

21 Sep 2023 According to a Synairgen media release, company's goal to commence trials as soon as possible, subject to approval timelines, and within H1 2024.
03 May 2023 New trial record
27 Apr 2023 According to a Synairgen media release, preparation is underway to initiate this study in 2H 2023 required for a regulatory submission.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com